Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Recludix pharma is a developing platform to treat cancer patients.
CrossBridge Bio operates as a biotechnology company.
Eclipse Bioinnovations is an RNA genomics company that provides products and services to academic and industry customers around the world.
Accipiter Biosciences is a biotechnology company.
Tr1x is a biotechnology company developing novel cellular immunotherapies for patients with autoimmune and inflammatory diseases.
NILO Therapeutics is a biotechnology and therapeutics company.
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
Thryv Therapeutics is a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias.
Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders
HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome.
Leal Therapeutics develops novel therapeutics for patients.
Harpe Bio develops sustainable weed control solutions for organic and industrial agriculture.
Dispatch Biotherapeutics develops immunotherapy that treats solid tumors, which could significantly advance cancer treatment options.
Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience.
March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers.
Hoofprint Biome is a biotechnology company that develops probiotics that improve the sustainability of ruminant livestock production.
Solu Therapeutics Platform Company that develops antibody-based medicines using a degradable warhead.
AIRNA develops RNA editing technologies to create medicines for various diseases.
Stratus Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.
Meiogenix is a biotechnology company that develops breeding technologies.
OverT Bio operates as a biotech company that provide cell therapy for cancers.
Autoimmunity BioSolutions develops a future immuno-corrective treatment that restores healthy immune function.
Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies .
Alexandria Venture Investments has invested in 187 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Alexandria Venture Investments's top investment sectors include Biotechnology, Therapeutics, Health Care, Life Science, Medical. The firm invests across 17 different industry categories.
Among tracked funding rounds, Dispatch Bio received $216.0M in a Series A round. Alexandria Venture Investments's total known invested capital is $7.0B.
Alexandria Venture Investments's average investment size is $41.5M across its portfolio of 187 companies.
Recent Alexandria Venture Investments portfolio additions include Recludix Pharma, CrossBridge Bio, Eclipse Bioinnovations, Accipiter Biosciences, Tr1x. These companies were founded in 2020 or later.